64 results
8-K
EX-99.1
NTBL
Notable Labs Ltd
12 Apr 24
Notable Labs Reports 2023 Financial Results and Provides a Business Update
8:44am
historical standards of care, Notable aims to create a dramatically positive impact for patients and the healthcare community. Notable is headquartered
8-K
EX-99.1
NTBL
Notable Labs Ltd
9 Apr 24
Notable Labs Presents the Design Plan for the PPMP-Enabled Phase 2 Trial with Volasertib for Relapsed/Refractory AML at AACR 2024
5:20pm
. By transforming historical standards of care, Notable aims to create a dramatically positive impact for patients and the healthcare community. Notable
8-K
EX-99.1
NTBL
Notable Labs Ltd
8 Apr 24
Other Events
12:15pm
a dramatically positive impact for patients and the healthcare community. Notable is headquartered in Foster City, California. Learn more at our website
8-K
EX-99.1
1uae7kss3xfvx ph
22 Feb 24
Other Events
8:15am
DEF 14A
my2s3v phg
16 Feb 24
Definitive proxy
9:00am
PRE 14A
21dopl6g1
5 Feb 24
Preliminary proxy
5:00pm
8-K
EX-99.1
4j3r3hazvyswjng wu
18 Dec 23
Other Events
8:15am
8-K
EX-99.1
e51ssj7d2d9
14 Nov 23
Notable Labs Announces Filing of Form 10-Q for Third Quarter 2023
12:00am
S-3
9tq4hbybe7piy6
17 Oct 23
Shelf registration
5:01pm
8-K
3b53x7j3tgp
16 Oct 23
Notable Labs Closes Merger Transaction With VBL Therapeutics
4:05pm
8-K
EX-99.1
ziewh3ldyuem
16 Oct 23
Notable Labs Closes Merger Transaction With VBL Therapeutics
4:05pm
8-K
EX-10.1
3415irrdmsdfodzy
12 Oct 23
Submission of Matters to a Vote of Security Holders
4:26pm
424B3
qbxj g5sttoo
5 Sep 23
Prospectus supplement
6:02pm
S-4/A
y3sejx5i1s
30 Jun 23
Registration of securities issued in business combination transactions (amended)
4:38pm